Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Esteva

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Nature Biomedical Engineering|April 7, 2020
A mountable toilet system for personalized health monitoring via the analysis of excretaSeung-Min Park, Daeyoun D Won, Brian J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancerJarey H Wang, Matthew P Deek, Adrianna A Mendes, et al.
JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.
Research Square|May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
NPJ Digital Medicine|February 22, 2023
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
European Urology Oncology|February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 TrialAshley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Biomedical Engineering|April 7, 2020
A mountable toilet system for personalized health monitoring via the analysis of excretaSeung-Min Park, Daeyoun D Won, Brian J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancerJarey H Wang, Matthew P Deek, Adrianna A Mendes, et al.
JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.
Research Square|May 3, 2023
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
NPJ Digital Medicine|February 22, 2023
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
European Urology Oncology|February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 TrialAshley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.
Pageof 4